...AmorChem’s spinouts include cancer company SpecificiT Pharma Inc., ophthalmology play SemaThera Inc. and inflammation companies Mperia Therapeutics Inc....

...also named Maxime Ranger general partner. Ranger is president and CEO of AmorChem portfolio company Mperia Therapeutics Inc....
...fund in 2011 at C$41.3 million ($32.5 million). AmorChem Group, Montreal, Quebec Allison Johnson AmorChem Merck & Co. Inc. Mperia Therapeutics Inc....

...also named Maxime Ranger general partner. Ranger is president and CEO of AmorChem portfolio company Mperia Therapeutics Inc....